Lumakras
FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved sotorasib (Lumakras, Amgen) with panitumumab (Vectibix, Amgen) for adult patients with KRAS ...
JANUARY 21, 2025
FDA Approves First KRAS-Targeted Therapy, Lumakras, for NSCLC
The FDA granted accelerated approval to the RAS GTPase inhibitor sotorasib (Lumakras, Amgen) for the treatment of ...
JUNE 7, 2021
Load more